Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives.
Costanzo R, Montanino A, Di Maio M, Piccirillo MC, Sandomenico C, Giordano P, Daniele G, Franco R, Perrone F, Rocco G, Normanno N, Morabito A. Costanzo R, et al. Among authors: normanno n. Expert Rev Anticancer Ther. 2013 Oct;13(10):1207-18. doi: 10.1586/14737140.2013.845092. Expert Rev Anticancer Ther. 2013. PMID: 24134422 Review.
Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
Pasquale R, Fenizia F, Esposito Abate R, Sacco A, Esposito C, Forgione L, Rachiglio AM, Bevilacqua S, Montanino A, Franco R, Rocco G, Botti G, Denis MG, Morabito A, De Luca A, Normanno N. Pasquale R, et al. Among authors: normanno n. Pharmacogenomics. 2015;16(10):1135-48. doi: 10.2217/pgs.15.45. Epub 2015 Aug 7. Pharmacogenomics. 2015. PMID: 26249748
The prognostic role of circulating tumor cells in lung cancer.
Normanno N, De Luca A, Gallo M, Chicchinelli N, Rossi A. Normanno N, et al. Expert Rev Anticancer Ther. 2016 Aug;16(8):859-67. doi: 10.1080/14737140.2016.1202767. Epub 2016 Jun 30. Expert Rev Anticancer Ther. 2016. PMID: 27337696 Review.
Targeting the EGFR T790M mutation in non-small-cell lung cancer.
Normanno N, Maiello MR, Chicchinelli N, Iannaccone A, Esposito C, De Cecio R, D'alessio A, De Luca A. Normanno N, et al. Expert Opin Ther Targets. 2017 Feb;21(2):159-165. doi: 10.1080/14728222.2017.1272582. Epub 2016 Dec 23. Expert Opin Ther Targets. 2017. PMID: 28002980 Review.
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer.
Gallo M, De Luca A, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Forgione L, Piccirillo MC, Rocco G, Morabito A, Botti G, Normanno N. Gallo M, et al. Among authors: normanno n. Transl Lung Cancer Res. 2017 Aug;6(4):486-498. doi: 10.21037/tlcr.2017.05.07. Transl Lung Cancer Res. 2017. PMID: 28904891 Free PMC article. Review.
Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC).
Vecchiarelli S, Passiglia F, D'Incecco A, Gallo M, De Luca A, Rossi E, D'Incà F, Minuti G, Landi L, Bennati C, Spreafico M, D'Arcangelo M, Mazza V, Normanno N, Cappuzzo F. Vecchiarelli S, et al. Among authors: normanno n. Oncotarget. 2018 Apr 3;9(25):17554-17563. doi: 10.18632/oncotarget.24785. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707129 Free PMC article.
The role of circulating free DNA in the management of NSCLC.
Esposito Abate R, Pasquale R, Fenizia F, Rachiglio AM, Roma C, Bergantino F, Forgione L, Lambiase M, Sacco A, Piccirillo MC, Morabito A, Normanno N. Esposito Abate R, et al. Among authors: normanno n. Expert Rev Anticancer Ther. 2019 Jan;19(1):19-28. doi: 10.1080/14737140.2019.1548938. Epub 2018 Nov 29. Expert Rev Anticancer Ther. 2019. PMID: 30462523 Review.
364 results